Nu-Med Plus, Inc. (NUMD) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
455 EAST 500 SOUTH, SUITE #203 SALT LAKE CITY, UT 84111 |
| State of Incorp. | UT |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 7 | 73 | 12 | 189 | 7 | 168 | |||
| Cash and cash equivalents | 7 | 73 | 12 | 189 | 7 | 168 | |||
| Prepaid expense | 7 | 6 | 349 | 7 | 219 | ||||
| Total current assets: | 13 | 80 | 12 | 538 | 14 | 386 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 8 | 8 | 8 | ✕ | |||||
| Property, plant and equipment | 90 | 2 | 12 | 23 | 37 | ||||
| Other undisclosed noncurrent assets | (90) | ||||||||
| Total noncurrent assets: | 10 | 20 | 32 | 37 | |||||
| TOTAL ASSETS: | 13 | 80 | 22 | 557 | 46 | 423 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 14 | 8 | 120 | 52 | 49 | 127 | |||
| Accounts payable | 8 | 7 | 28 | 26 | 40 | 10 | |||
| Accrued liabilities | 6 | 1 | 93 | 26 | 10 | 118 | |||
| Debt | 100 | 100 | 230 | 241 | |||||
| Due to related parties | ✕ | ✕ | 34 | 26 | 20 | 114 | 6 | ||
| Other undisclosed current liabilities | 46 | 8 | 8 | 22 | |||||
| Total current liabilities: | 160 | 143 | 155 | 80 | 416 | 374 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 9 | ||||||||
| Long-term debt, excluding current maturities | 9 | ||||||||
| Total noncurrent liabilities: | 9 | ||||||||
| Total liabilities: | 160 | 143 | 155 | 89 | 416 | 374 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (147) | (63) | (132) | 468 | (370) | 49 | |||
| Common stock | 84 | 81 | 79 | 51 | 44 | 41 | |||
| Common stock, share subscribed but unissued, subscriptions receivable | (724) | (466) | (849) | ||||||
| Common stock, value, subscriptions | 724 | 752 | 60 | ||||||
| Additional paid in capital | 9,595 | 9,555 | 9,358 | 8,432 | 5,850 | 4,851 | |||
| Accumulated deficit | (9,825) | (9,699) | (9,569) | (8,739) | (6,730) | (5,693) | |||
| Stockholders' equity note, subscriptions receivable | 466 | 849 | |||||||
| Other undisclosed equity, attributable to parent | 724 | (286) | 789 | ||||||
| Total equity: | (147) | (63) | (132) | 468 | (370) | 49 | |||
| TOTAL LIABILITIES AND EQUITY: | 13 | 80 | 22 | 557 | 46 | 423 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 52 | 9 | ||||||
| Other income | (5) | 52 | 9 | (14) | (17) | (19) | ||
| Gross profit: | 52 | 9 | ||||||
| Operating expenses | (121) | (182) | (839) | (1,995) | (1,019) | (1,169) | ||
| Other operating expense, net (Other Expenses) | (1) | |||||||
| Other undisclosed operating income (loss) | 5 | (52) | (9) | 14 | 17 | |||
| Operating loss: | (121) | (182) | (839) | (1,995) | (1,019) | (1,189) | ||
| Nonoperating income (expense) | 0 | |||||||
| Investment income, nonoperating | 0 | |||||||
| Interest and debt expense | 49 | 9 | (14) | 17 | 20 | |||
| Other undisclosed income from continuing operations before equity method investments, income taxes | ||||||||
| Loss from continuing operations before equity method investments, income taxes: | (121) | (133) | (830) | (2,009) | (1,002) | (1,169) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (5) | 3 | ||||||
| Loss from continuing operations before income taxes: | (126) | (130) | (830) | (2,009) | (1,002) | (1,169) | ||
| Income tax expense | (0) | |||||||
| Loss from continuing operations: | (126) | (130) | (830) | (2,009) | (1,002) | (1,169) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (830) | (2,009) | (1,002) | (1,169) | |
| Net loss: | (126) | (130) | (830) | (2,009) | (1,002) | (1,169) | ||
| Other undisclosed net loss attributable to parent | (35) | (20) | ||||||
| Net loss available to common stockholders, diluted: | (126) | (130) | (830) | (2,009) | (1,037) | (1,189) | ||
Comprehensive Income ($ in thousands)
| 3/31/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (126) | (130) | (830) | (2,009) | (1,002) | (1,169) | ||
| Comprehensive loss, net of tax, attributable to parent: | (126) | (130) | (830) | (2,009) | (1,002) | (1,169) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.